Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Manitex Capital Inc. (V:MNX)

Business Focus: Pharmaceuticals (NEC)

Sector:  Healthcare Industry:  Pharmaceuticals
 
Company Contact
Address: 16667 Hymus Blvd
KIRKLAND QC H9H 4R9
Tel: N/A
Website: N/A
IR: N/A
Key People
Steven Saviuk
Chairman of the Board, President, Chief Executive Officer
Helen Saviuk
Chief Financial Officer, Director
 
Business Overview
Manitex Capital Inc. is a Canada-based Diversified investment company. The Company is specialized in investing in emerging as well as established companies in diversified sectors, including life sciences and sustainable products/technologies. The Company also holds an extensive portfolio in marketable securities in companies in the same fields.
Financial Overview
For the three months ended 31 January 2024, Manitex Capital Inc. revenues was not reported. Net income totaled C$73K vs. loss of C$508K. Net income reflects FV Adjustments of Financial Investments increase from C$243K (expense) to C$105K (income), G/L on Invest. HFS, Maturity & Trading decrease from C$39K (expense) to C$0K, Management compensation decrease from C$7K (expense) to C$0K.
Reporting Currency: Canadian Dollars
Enterprise value: $1.00M as of Jan 31, 2024
Annual revenue (TTM): $0.00M as of Jan 31, 2024
EBITDA (TTM): -$0.61M as of Jan 31, 2024
Net annual income (TTM): $0.84M as of Jan 31, 2024
Free cash flow (TTM): -$0.12M as of Jan 31, 2024
Net Debt Last Fiscal Year: N/A
Shares outstanding: 12,661,276 as of Jan 31, 2024
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization